Failure-probability driven dose painting

Medical Physics

Volumn 40, Issue 8, 2013, Pages

  Vogelius, Ivan R ^a   Håkansson, Katrin ^a   Due, Anne K ^a   Aznar, Marianne C ^a   Berthelsen, Anne K ^a   Kristensen, Claus A ^a   Rasmussen, Jacob ^a   Specht, Lena ^a   Bentzen, Søren M ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

dose painting; FDG PET; head and neck cancer; radiotherapy

Indexed keywords

PATIENT MONITORING; RADIOTHERAPY; RISK PERCEPTION; SPATIAL DISTRIBUTION; TRANSMISSION CONTROL PROTOCOL; TUMORS;

CLINICAL RESPONSE; DOSE PAINTINGS; DOSE PRESCRIPTION; DOSE-RESPONSE MODELING; FAILURE PROBABILITY; FDG PET; HEAD-AND-NECK CANCER; TUMOR CONTROL PROBABILITY;

PROBABILITY DISTRIBUTIONS;

ARTICLE; CANCER CONTROL; CLINICAL ARTICLE; DOSE RESPONSE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROBABILITY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; STATISTICAL MODEL; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR VOLUME; NEOPLASM; TREATMENT FAILURE; NEOPLASMS;

HUMANS; MODELS, STATISTICAL; NEOPLASMS; PROBABILITY; RADIATION DOSAGE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT FAILURE;

EID: 84881620965     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.4816308     Document Type: Article

References (21)

1. S. M. Bentzen, " Radiobiological considerations in the design of clinical trials.," Radiother. Oncol. 32, 1-11 (1994). 10.1016/0167-8140(94) 90443-X
2. A. Sovik, " Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: A modelling study.," Phys. Med. Biol. 52, 499-513 (2007). 10.1088/0031-9155/52/2/013
3. A. Brahme and A. K. Agren, " Optimal dose distribution for eradication of heterogeneous tumours.," Acta Oncol. 26, 377-385 (1987). 10.3109/02841868709104364
4. I. Madani, " Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer.," Int. J. Radiat. Oncol., Biol., Phys. 68, 126-135 (2007). 10.1016/j.ijrobp.2006.12.070
5. S. M. Bentzen and V. Gregoire, " Molecular imaging-based dose painting: A novel paradigm for radiation therapy prescription.," Semin. Radiat. Oncol. 21, 101-110 (2011). 10.1016/j.semradonc.2010.10.001
6. A. Due, " OC-0148 head and neck cancer recurrence density in relation to FDG-PET and clinical IMRT target volumes.," Radiother. Oncol. 103 (Suppl 1), S57 (2012). 10.1016/S0167-8140(12)70487-5
7. A. K. Due, " Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma.," Strahlenther. Onkol. 188, 671-676 (2012). 10.1007/s00066-012-0127-y
8. S. M. Bentzen and S. L. Tucker, " Quantifying the position and steepness of radiation dose-response curves.," Int. J. Radiat. Biol. 71, 531-542 (1997). 10.1080/095530097143860
9. W. Mendenhall and R. Million, " Elective neck irradiation for squamous cell carcinoma of the head and neck: Analysis of time-dose factors and causes of failure.," Int. J. Radiat. Oncol., Biol., Phys. 12, 741-746 (1986). 10.1016/0360-3016(86)90031-3
10. W. Mendenhall, R. Million, and N. Cassisi, " Squamous cell carcinoma of the head and neck treated with radiation therapy: The role of neck dissection for clinically positive neck nodes.," Int. J. Radiat. Oncol., Biol., Phys. 12, 733-740 (1986). 10.1016/0360-3016(86)90030-1
11. C. O'Brien, " The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx.," Arch. Otolaryngol. Head Neck Surg. 126, 360-365 (2000). 10.1001/archotol.126.3.360
12. A. Eisbruch, " Intensity-modulated radiation therapy for head and neck cancer: Emphasis on the selection and delineation of the targets.," Semin. Radiat. Oncol. 12, 238-249 (2002). 10.1053/srao.2002.32435
13. G. Fletcher, " Elective irradiation of subclinical disease in cancers of the head and neck.," Cancer 29, 1450 (1972). 10.1002/1097-0142(197206)29:6<1450::AID-CNCR2820290605>3.0.CO;2-Q
14. I. Madani, " Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer.," Radiother. Oncol. 101, 351-355 (2011). 10.1016/j.radonc.2011.06.020
15. A. C. Houweling, " A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients.," Int. J. Radiat. Oncol., Biol., Phys. 76, 1259-1265 (2010). 10.1016/j.ijrobp.2009.07.1685
16. C. A. Murdoch-Kinch, " Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy.," Int. J. Radiat. Oncol., Biol., Phys. 72, 373-382 (2008). 10.1016/j.ijrobp.2007.12.033
17. I. Beetz, " NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: The role of dosimetric and clinical factors.," Radiother. Oncol. 105, 101-106 (2012). 10.1016/j.radonc.2012.03.004
18. F. Duprez, " Adaptive dose painting by numbers for head-and-neck cancer.," Int. J. Radiat. Oncol., Biol., Phys. 80, 1045-1055 (2011). 10.1016/j.ijrobp.2010.03.028
19. J. O'Quigley, M. Pepe, and L. Fisher, " Continual reassessment method: A practical design for phase 1 clinical trials in cancer.," Biometrics 46, 33-48 (1990). 10.2307/2531628
20. A. K. Due, " Methodologies for localizing loco-regional hypopharyngeal carcinoma recurrences in relation to FDG-PET positive and clinical radiation therapy target volumes.," Acta Oncol. 49, 984-990 (2010). 10.3109/0284186X.2010.498833
21. See supplementary material at http://dx.doi.org/10.1118/1.4816308 E-MPHYA6-40-070308 for the Appendix.